Article
Nexus Between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
2020-12-28
Abstract excerpt
Signaling from estrogen receptor alpha (ER) and its ligand estradiol (E2) is critical for growth of ~70% of breast cancers. Therefore, several drugs that inhibit ER functions are in clinical use for decades and new classes of anti-estrogens are continuously being developed. Although a significant number of ER+ breast cancers respond to anti-estrogen therapy, ~30% of these breast cancers recur, sometimes even af...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8b48685-9cdd-5935-9398-225f2e6c4f1b
- DOI
- 10.20944/preprints202012.0675.v1
